American Pharmaceutical Review 17 March 2022 Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
GlobalData 6 January 2022 Akston Biosciences seeks USD 10m–25m raise, plans for further COVID-19 vaccine booster trials
11 November 2021 ‘Looking forward to second-gen vaccines,’ says WHO chief: From nasal sprays to multivariant jabs, vaccines in development spur hope of ending the pandemic
7 September 2021 Second-generation vaccines offer a chance to correct flaws in early vaccination campaigns